Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bolt Biotherapeutics Inc (NASDAQ: BOLT)

 
BOLT Technical Analysis
5
As on 3rd Jul 2025 BOLT SHARE Price closed @ 5.92 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.86 & Strong Buy for SHORT-TERM with Stoploss of 1.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BOLTSHARE Price

Open 5.91 Change Price %
High 6.04 1 Day 0.01 0.17
Low 5.91 1 Week 0.33 5.90
Close 5.92 1 Month 5.59 1693.94
Volume 928 1 Year 4.78 419.30
52 Week High 6.64 | 52 Week Low 0.29
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 2.16 5.37%
HCTI 0.03 50.00%
NVDA 159.34 1.33%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PLUG 1.47 5.00%
WINT 0.93 20.78%
BTBT 2.94 11.79%
LILM 0.05 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
CTHR 0.22 -77.08%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
BOLT
Daily Charts		 BOLT
Intraday Charts		 Whats New @
Bazaartrend		 BOLT
Free Analysis
 
BOLT Important Levels Intraday
RESISTANCE6.17
RESISTANCE6.09
RESISTANCE6.04
RESISTANCE5.99
SUPPORT5.85
SUPPORT5.80
SUPPORT5.75
SUPPORT5.67
 
BOLT Forecast July 2025
Share
4th UP Forecast6.4
3rd UP Forecast6.25
2nd UP Forecast6.15
1st UP Forecast6.06
1st DOWN Forecast5.78
2nd DOWN Forecast5.69
3rd DOWN Forecast5.59
4th DOWN Forecast5.44
 
BOLT Weekly Forecast
4th UP Forecast6.23
3rd UP Forecast6.13
2nd UP Forecast6.07
1st UP Forecast6.01
1st DOWN Forecast5.83
2nd DOWN Forecast5.77
3rd DOWN Forecast5.71
4th DOWN Forecast5.61
 
BOLT Forecast2025
4th UP Forecast19.58
3rd UP Forecast15.2
2nd UP Forecast12.49
1st UP Forecast9.78
1st DOWN Forecast2.06
2nd DOWN Forecast-0.65
3rd DOWN Forecast-3.36
4th DOWN Forecast-7.74
 
 
BOLT Other Details
Segment EQ
Market Capital 475061888.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BOLT Address
BOLT
 
BOLT Latest News
 
Your Comments and Response on Bolt Biotherapeutics Inc
 
BOLT Business Profile
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; and BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California. Address: 900 Chesapeake Drive, Redwood City, CA, United States, 94063
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service